Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-05

Clinical Trial Update: Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Simvastatin and Duavee for endometriosis and microvascular dysfunction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duavee (bazedoxifene/conjugated estrogens)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Penn State University | Conditions: Endometriosis | Phase 4 | Status: RECRUITING